Loading clinical trials...
Loading clinical trials...
This study will investigate whether CX516 can improve attention, memory, language, or behavior in adults with Fragile X Syndrome and/or Autism. CX516 is an AMPAKINE® compound. AMPAKINE compounds enha...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
RespireRx
Collaborators
NCT04026386 · Development Disorder, Child, Developmental Disability, and more
NCT07209462 · Fragile X Syndrome
NCT07624448 · Autism, Intellectual Disabilities With Other Behavioral Symptoms, and more
NCT06875843 · Autism
NCT07216196 · Autism
UC Davis-MIND Institute
Sacramento, California
RUSH-Presbyterian-St. Luke's Medical Center
Chicago, Illinois
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions